Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12969-015-0047-3.

Title:
Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity | Pediatric Rheumatology
Description:
Background Adult-onset Still’s disease (AOSD), a rare autoinflammatory disorder, resembles systemic juvenile idiopathic arthritis (SJIA). The superimposable systemic clinical features of AOSD and SJIA suggest both clinical phenotypes represent the same disease continuum with different ages of onset. To further characterize the similarity between AOSD and SJIA at the molecular level, 2 previously identified response gene sets in SJIA were used to investigate how genes that respond to interleukin (IL)-1β inhibition with canakinumab in SJIA patients behave in AOSD patients with active disease prior to IL-1β targeting therapy, relative to healthy subjects. Findings All genes downregulated in SJIA patients following canakinumab treatment were upregulated in most patients with active AOSD prior to canakinumab treatment, relative to healthy subjects. A few patients with milder AOSD had expectedly gene-expression patterns that resembled those in healthy subjects. Comparison of the gene-expression patterns with neutrophil counts showed a correlation between elevated neutrophil numbers and upregulation of canakinumab-responsive genes. Correspondingly, most genes upregulated following canakinumab treatment in patients with SJIA patients were downregulated in the majority of AOSD patients. Conclusions These results further support the concept of a Still’s disease continuum that includes both a pediatric/juvenile onset (SJIA) and adult onset (AOSD) form.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

patients, aosd, disease, sjia, canakinumab, article, pubmed, stills, genes, google, scholar, arthritis, treatment, cas, systemic, analysis, juvenile, adultonset, healthy, subjects, geneexpression, idiopathic, clinical, expression, onset, novartis, data, blood, gene, samples, research, ilβ, values, rheum, including, rheumatology, therapy, adult, shown, germany, rheumatol, prior, upregulated, support, study, continuum, interleukin, relative, downregulated, pathogenesis,

Topics {✒️}

il-1β long-acting inhibitor anti − il-1β therapy article download pdf gene-expression profiles christof specker expectedly gene-expression patterns previous gene-expression analysis il-1β targeting therapy anti − il1-β therapy present gene-expression analysis 1st-strand cdna synthesis 2nd-strand cdna synthesis il1-receptor antagonist anakinra received grants/research support pediatric/juvenile onset ribo-spia® amplification process single disease entity aosd gene-expression patterns full size image il-1–driven condition similar il-1r inhibitor anakinra gov/ct2/show/nct02204293 identify canakinumab-responsive genes gene-expression patterns macrophage activation syndrome blood cell counts author information authors privacy choices/manage cookies active systemic features probe sets identified gene-expression values innate-immunity–related genes gene expression profiling neutrophil counts showed gene-expression analysis elevated neutrophil numbers arthritis res ther ovation wb reagent creative commons license il-1β inhibition immune-cell activity semin arthritis rheum rare autoinflammatory disorder gene-expression data gene expression data il-1 − driven condition treatment-resistant adult-onset norbert blank innate immune system support research activities

Questions {❓}

  • Adult-onset Still’s disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity
         description:Adult-onset Still’s disease (AOSD), a rare autoinflammatory disorder, resembles systemic juvenile idiopathic arthritis (SJIA). The superimposable systemic clinical features of AOSD and SJIA suggest both clinical phenotypes represent the same disease continuum with different ages of onset. To further characterize the similarity between AOSD and SJIA at the molecular level, 2 previously identified response gene sets in SJIA were used to investigate how genes that respond to interleukin (IL)-1β inhibition with canakinumab in SJIA patients behave in AOSD patients with active disease prior to IL-1β targeting therapy, relative to healthy subjects. All genes downregulated in SJIA patients following canakinumab treatment were upregulated in most patients with active AOSD prior to canakinumab treatment, relative to healthy subjects. A few patients with milder AOSD had expectedly gene-expression patterns that resembled those in healthy subjects. Comparison of the gene-expression patterns with neutrophil counts showed a correlation between elevated neutrophil numbers and upregulation of canakinumab-responsive genes. Correspondingly, most genes upregulated following canakinumab treatment in patients with SJIA patients were downregulated in the majority of AOSD patients. These results further support the concept of a Still’s disease continuum that includes both a pediatric/juvenile onset (SJIA) and adult onset (AOSD) form.
         datePublished:2015-11-20T00:00:00Z
         dateModified:2015-11-20T00:00:00Z
         pageStart:1
         pageEnd:6
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12969-015-0047-3
         keywords:
            Adult-onset Still’s disease
            Canakinumab
            Gene expression
            Interleukin-1β
            Systemic juvenile idiopathic arthritis
            Pediatrics
            Rheumatology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12969-015-0047-3/MediaObjects/12969_2015_47_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12969-015-0047-3/MediaObjects/12969_2015_47_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12969-015-0047-3/MediaObjects/12969_2015_47_Fig3_HTML.gif
         isPartOf:
            name:Pediatric Rheumatology
            issn:
               1546-0096
            volumeNumber:13
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Nanguneri Nirmala
               affiliation:
                     name:Novartis Institutes for BioMedical Research, Inc.
                     address:
                        name:Novartis Institutes for BioMedical Research, Inc., Cambridge, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Arndt Brachat
               affiliation:
                     name:Novartis Institutes for Biomedical Research
                     address:
                        name:Novartis Institutes for Biomedical Research, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eugen Feist
               affiliation:
                     name:Charité- Universitätsmedizin
                     address:
                        name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Norbert Blank
               affiliation:
                     name:University of Heidelberg
                     address:
                        name:Division of Rheumatology, Department of Medicine, University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christof Specker
               affiliation:
                     name:SJK – University Hospital Essen
                     address:
                        name:Klinik für Rheumatologie & Klinische Immunologie, SJK – University Hospital Essen, Essen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Matthias Witt
               affiliation:
                     name:University of Munich
                     address:
                        name:Division of Rheumatology and Clinical Immunology, Med. Klinik and Poliklinik IV, University of Munich, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jan Zernicke
               affiliation:
                     name:Charité- Universitätsmedizin
                     address:
                        name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alberto Martini
               affiliation:
                     name:University of Genoa and G Gaslini Institute
                     address:
                        name:University of Genoa and G Gaslini Institute, Genoa, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guido Junge
               affiliation:
                     name:Novartis Pharma AG
                     address:
                        name:Novartis Pharma AG, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity
      description:Adult-onset Still’s disease (AOSD), a rare autoinflammatory disorder, resembles systemic juvenile idiopathic arthritis (SJIA). The superimposable systemic clinical features of AOSD and SJIA suggest both clinical phenotypes represent the same disease continuum with different ages of onset. To further characterize the similarity between AOSD and SJIA at the molecular level, 2 previously identified response gene sets in SJIA were used to investigate how genes that respond to interleukin (IL)-1β inhibition with canakinumab in SJIA patients behave in AOSD patients with active disease prior to IL-1β targeting therapy, relative to healthy subjects. All genes downregulated in SJIA patients following canakinumab treatment were upregulated in most patients with active AOSD prior to canakinumab treatment, relative to healthy subjects. A few patients with milder AOSD had expectedly gene-expression patterns that resembled those in healthy subjects. Comparison of the gene-expression patterns with neutrophil counts showed a correlation between elevated neutrophil numbers and upregulation of canakinumab-responsive genes. Correspondingly, most genes upregulated following canakinumab treatment in patients with SJIA patients were downregulated in the majority of AOSD patients. These results further support the concept of a Still’s disease continuum that includes both a pediatric/juvenile onset (SJIA) and adult onset (AOSD) form.
      datePublished:2015-11-20T00:00:00Z
      dateModified:2015-11-20T00:00:00Z
      pageStart:1
      pageEnd:6
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12969-015-0047-3
      keywords:
         Adult-onset Still’s disease
         Canakinumab
         Gene expression
         Interleukin-1β
         Systemic juvenile idiopathic arthritis
         Pediatrics
         Rheumatology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12969-015-0047-3/MediaObjects/12969_2015_47_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12969-015-0047-3/MediaObjects/12969_2015_47_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12969-015-0047-3/MediaObjects/12969_2015_47_Fig3_HTML.gif
      isPartOf:
         name:Pediatric Rheumatology
         issn:
            1546-0096
         volumeNumber:13
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Nanguneri Nirmala
            affiliation:
                  name:Novartis Institutes for BioMedical Research, Inc.
                  address:
                     name:Novartis Institutes for BioMedical Research, Inc., Cambridge, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Arndt Brachat
            affiliation:
                  name:Novartis Institutes for Biomedical Research
                  address:
                     name:Novartis Institutes for Biomedical Research, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eugen Feist
            affiliation:
                  name:Charité- Universitätsmedizin
                  address:
                     name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Norbert Blank
            affiliation:
                  name:University of Heidelberg
                  address:
                     name:Division of Rheumatology, Department of Medicine, University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christof Specker
            affiliation:
                  name:SJK – University Hospital Essen
                  address:
                     name:Klinik für Rheumatologie & Klinische Immunologie, SJK – University Hospital Essen, Essen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Matthias Witt
            affiliation:
                  name:University of Munich
                  address:
                     name:Division of Rheumatology and Clinical Immunology, Med. Klinik and Poliklinik IV, University of Munich, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jan Zernicke
            affiliation:
                  name:Charité- Universitätsmedizin
                  address:
                     name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alberto Martini
            affiliation:
                  name:University of Genoa and G Gaslini Institute
                  address:
                     name:University of Genoa and G Gaslini Institute, Genoa, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guido Junge
            affiliation:
                  name:Novartis Pharma AG
                  address:
                     name:Novartis Pharma AG, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Pediatric Rheumatology
      issn:
         1546-0096
      volumeNumber:13
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Novartis Institutes for BioMedical Research, Inc.
      address:
         name:Novartis Institutes for BioMedical Research, Inc., Cambridge, USA
         type:PostalAddress
      name:Novartis Institutes for Biomedical Research
      address:
         name:Novartis Institutes for Biomedical Research, Basel, Switzerland
         type:PostalAddress
      name:Charité- Universitätsmedizin
      address:
         name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
         type:PostalAddress
      name:University of Heidelberg
      address:
         name:Division of Rheumatology, Department of Medicine, University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:SJK – University Hospital Essen
      address:
         name:Klinik für Rheumatologie & Klinische Immunologie, SJK – University Hospital Essen, Essen, Germany
         type:PostalAddress
      name:University of Munich
      address:
         name:Division of Rheumatology and Clinical Immunology, Med. Klinik and Poliklinik IV, University of Munich, Munich, Germany
         type:PostalAddress
      name:Charité- Universitätsmedizin
      address:
         name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
         type:PostalAddress
      name:University of Genoa and G Gaslini Institute
      address:
         name:University of Genoa and G Gaslini Institute, Genoa, Italy
         type:PostalAddress
      name:Novartis Pharma AG
      address:
         name:Novartis Pharma AG, Basel, Switzerland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Nanguneri Nirmala
      affiliation:
            name:Novartis Institutes for BioMedical Research, Inc.
            address:
               name:Novartis Institutes for BioMedical Research, Inc., Cambridge, USA
               type:PostalAddress
            type:Organization
      name:Arndt Brachat
      affiliation:
            name:Novartis Institutes for Biomedical Research
            address:
               name:Novartis Institutes for Biomedical Research, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Eugen Feist
      affiliation:
            name:Charité- Universitätsmedizin
            address:
               name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Norbert Blank
      affiliation:
            name:University of Heidelberg
            address:
               name:Division of Rheumatology, Department of Medicine, University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Christof Specker
      affiliation:
            name:SJK – University Hospital Essen
            address:
               name:Klinik für Rheumatologie & Klinische Immunologie, SJK – University Hospital Essen, Essen, Germany
               type:PostalAddress
            type:Organization
      name:Matthias Witt
      affiliation:
            name:University of Munich
            address:
               name:Division of Rheumatology and Clinical Immunology, Med. Klinik and Poliklinik IV, University of Munich, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Jan Zernicke
      affiliation:
            name:Charité- Universitätsmedizin
            address:
               name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Alberto Martini
      affiliation:
            name:University of Genoa and G Gaslini Institute
            address:
               name:University of Genoa and G Gaslini Institute, Genoa, Italy
               type:PostalAddress
            type:Organization
      name:Guido Junge
      affiliation:
            name:Novartis Pharma AG
            address:
               name:Novartis Pharma AG, Basel, Switzerland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Novartis Institutes for BioMedical Research, Inc., Cambridge, USA
      name:Novartis Institutes for Biomedical Research, Basel, Switzerland
      name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
      name:Division of Rheumatology, Department of Medicine, University of Heidelberg, Heidelberg, Germany
      name:Klinik für Rheumatologie & Klinische Immunologie, SJK – University Hospital Essen, Essen, Germany
      name:Division of Rheumatology and Clinical Immunology, Med. Klinik and Poliklinik IV, University of Munich, Munich, Germany
      name:Department of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin, Berlin, Germany
      name:University of Genoa and G Gaslini Institute, Genoa, Italy
      name:Novartis Pharma AG, Basel, Switzerland

External Links {🔗}(122)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.21s.